Related references
Note: Only part of the references are listed.Focal white matter microstructural alteration after anthracycline-based systemic treatment in long-term breast cancer survivors: a structural magnetic resonance imaging study
Huawen Zhang et al.
BRAIN IMAGING AND BEHAVIOR (2022)
Research advances on how metformin improves memory impairment in chemobrain
Ahmad Alhowail et al.
NEURAL REGENERATION RESEARCH (2022)
Serum neurofilament light chain levels as biomarker of paclitaxel-induced cognitive impairment in patients with breast cancer: a prospective study
Andreas A. Argyriou et al.
SUPPORTIVE CARE IN CANCER (2022)
Chemotherapy-related subjective cognitive impairment in breast cancer patients in semi-rural South Africa
Nicholas M. Keetile et al.
HEALTH SA GESONDHEID (2021)
Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
N-Acetylcysteine Attenuates the Anxiety-Like Behavior and Spatial Cognition Impairment Induced by Doxorubicin and Cyclophosphamide Combination Treatment in Rats
Yoshihisa Kitamura et al.
PHARMACOLOGY (2021)
Examination of individual and multiple comorbid conditions and health-related quality of life in older cancer survivors
Elizabeth J. Siembida et al.
QUALITY OF LIFE RESEARCH (2021)
Cognitive impairment resulting from treatment with docetaxel, doxorubicin, and cyclophosphamide
Taurean Brown et al.
BRAIN RESEARCH (2021)
Nose-to-brain delivery of chrysin transfersomal and composite vesicles in doxorubicin-induced cognitive impairment in rats: Insights on formulation, oxidative stress and TLR4/NF-kB/NLRP3 pathways
Shaimaa S. Ibrahim et al.
NEUROPHARMACOLOGY (2021)
Prevalence of cognitive impairment and change in patients with breast cancer: A systematic review of longitudinal studies
Aicha B. C. Dijkshoorn et al.
PSYCHO-ONCOLOGY (2021)
Implications of Breast Cancer Chemotherapy-Induced Inflammation on the Gut, Liver, and Central Nervous System
Taurean Brown et al.
BIOMEDICINES (2021)
Doxorubicin-Induced Cognitive Impairment: The Mechanistic Insights
Jiajia Du et al.
FRONTIERS IN ONCOLOGY (2021)
Pharmacological rescue of cognitive function in a mouse model of chemobrain
Lien D. Nguyen et al.
MOLECULAR NEURODEGENERATION (2021)
Donepezil Protects Against Doxorubicin-Induced Chemobrain in Rats via Attenuation of Inflammation and Oxidative Stress Without Interfering With Doxorubicin Efficacy
Benjamin Ongnok et al.
NEUROTHERAPEUTICS (2021)
Protective effect of nanocurcumin against neurotoxicity induced by doxorubicin in rat's brain
Yasser A. Khadrawy et al.
NEUROTOXICOLOGY (2021)
Oxidative Stress and Cognitive Alterations Induced by Cancer Chemotherapy Drugs: A Scoping Review
Omar Cauli
ANTIOXIDANTS (2021)
Redox imbalance induced by docetaxel in the neuroblastoma SH-SY5Y cells: a study of docetaxel-induced neuronal damage
Lucia Micheli et al.
REDOX REPORT (2021)
Early Effects of Cyclophosphamide, Methotrexate, and 5-Fluorouracil on Neuronal Morphology and Hippocampal-Dependent Behavior in a Murine Model
Julie E. Anderson et al.
TOXICOLOGICAL SCIENCES (2020)
Polydatin ameliorates chemotherapy-induced cognitive impairment (chemobrain) by inhibiting oxidative stress, inflammatory response, and apoptosis in rats
Yifan Tong et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2020)
Doxorubicin and cisplatin induced cognitive impairment: The possible mechanisms and interventions
Benjamin Ongnok et al.
EXPERIMENTAL NEUROLOGY (2020)
Cognitive Impairment in Patients With Breast Cancer: Understanding the Impact of Chemotherapy and Endocrine Therapy
Patricia A. Ganz et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
A mouse model of chemotherapy-related cognitive impairments integrating the risk factors of aging and APOE4 genotype
Tamar C. Demby et al.
BEHAVIOURAL BRAIN RESEARCH (2020)
Taxane-induced neurotoxicity: Pathophysiology and therapeutic perspectives
Robson da Costa et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Cellular mechanisms and treatments for chemobrain: insight from aging and neurodegenerative diseases
Lien D. Nguyen et al.
EMBO MOLECULAR MEDICINE (2020)
Assessing the Effects of Redox Modifier MnTnBuOE-2-PyP 5+on Cognition and Hippocampal Physiology Following Doxorubicin, Cyclophosphamide, and Paclitaxel Treatment
Taylor McElroy et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Patient-Reported Cognitive Impairment Among Women With Early Breast Cancer Randomly Assigned to Endocrine Therapy Alone Versus Chemoendocrine Therapy: Results From TAILORx
Lynne Wagner et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Doxorubicin chemotherapy-induced chemo-brain: Meta-analysis
Sarah Eide et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
The Anti-Inflammatory Drug Aspirin Does Not Protect Against Chemotherapy-Induced Memory Impairment by Paclitaxel in Mice
Aeson Chang et al.
FRONTIERS IN ONCOLOGY (2020)
Dysfunction of Mitochondrial Ca2+ Regulatory Machineries in Brain Aging and Neurodegenerative Diseases
Hyunsu Jung et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Telomere lengths in women treated for breast cancer show associations with chemotherapy, pain symptoms, and cognitive domain measures: a longitudinal study
Areej A. Alhareeri et al.
BREAST CANCER RESEARCH (2020)
Cognitive impairment after cytotoxic chemotherapy
Petra Huehnchen et al.
NEURO-ONCOLOGY PRACTICE (2020)
Pharmacologic management of cognitive impairment induced by cancer therapy
Philipp Karschnia et al.
LANCET ONCOLOGY (2019)
Chemotherapy and cognition: comprehensive review on doxorubicin-induced chemobrain
Sara Emad El-Agamy et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2019)
Medhya Rasayana Restores Memory Function against Doxorubicin-induced Cognitive Decline: Possibly by its Neuroprotective Effect
Karthik Gourishetti et al.
INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH (2019)
Neuropsychological disorders in non-central nervous system cancer: a review of objective cognitive impairment, depression, and related rehabilitation options
Fulvia Di Iulio et al.
NEUROLOGICAL SCIENCES (2019)
Loss of Adaptive Myelination Contributes to Methotrexate Chemotherapy-Related Cognitive Impairment
Anna C. Geraghty et al.
NEURON (2019)
Spatial memory deficits in mice induced by chemotherapeutic agents are prevented by acetylcholinesterase inhibitors
Rex M. Philpot et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2019)
Breast cancer
Nadia Harbeck et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
The Effects of Doxorubicin-based Chemotherapy and Omega-3 Supplementation on Mouse Brain Lipids
Djawed Bennouna et al.
METABOLITES (2019)
Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors
M. Lange et al.
ANNALS OF ONCOLOGY (2019)
Emerging mechanistic underpinnings and therapeutic targets for chemotherapy-related cognitive impairment
Erin M. Gibson et al.
CURRENT OPINION IN ONCOLOGY (2019)
Nerolidol ameliorates cyclophosphamide-induced oxidative stress, neuroinflammation and cognitive dysfunction: Plausible role of Nrf2 and NF- κB
Ashif Iqubal et al.
LIFE SCIENCES (2019)
Attenuation of neuroinflammation reverses Adriamycin-induced cognitive impairments
Barrett D. Allen et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
Methotrexate Chemotherapy Induces Persistent Tri-glial Dysregulation that Underlies Chemotherapy-Related Cognitive Impairment
Erin M. Gibson et al.
CELL (2019)
Cognitive impairment following chemotherapy for breast cancer: The impact of practice effect on results
Noemi Cerulla et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY (2019)
Ginsenoside Rg1 Prevents Chemotherapy-Induced Cognitive Impairment: Associations with Microglia-Mediated Cytokines, Neuroinflammation, and Neuroplasticity
Dong-Dong Shi et al.
MOLECULAR NEUROBIOLOGY (2019)
Development of a Human APOE Knock-in Mouse Model for Study of Cognitive Function After Cancer Chemotherapy
Andrew P. Speidell et al.
NEUROTOXICITY RESEARCH (2019)
Preserved Memory Function of Rats Following Fluorouracil Treatment
Ahmad H. Alhowail
JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL (2019)
Verbal memory in breast cancer patients treated with chemotherapy with doxorubicin and cyclophosphamide
P. Andryszak et al.
EUROPEAN JOURNAL OF CANCER CARE (2018)
Astaxanthin Ameliorates Doxorubicin-Induced Cognitive Impairment (Chemobrain) in Experimental Rat Model: Impact on Oxidative, Inflammatory, and Apoptotic Machineries
Sara Emad El-Agamy et al.
MOLECULAR NEUROBIOLOGY (2018)
Effects of Cyclophosphamide and/or Doxorubicin in a Murine Model of Postchemotherapy Cognitive Impairment
Timothy J. Flanigan et al.
TOXICOLOGICAL SCIENCES (2018)
Association of Neurocognitive Deficits With Radiotherapy or Chemoradiotherapy for Patients With Head and Neck Cancer
Alona Zer et al.
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2018)
Impact of Adjuvant Anthracycline-Based and Taxane-Based Chemotherapy on Plasma VEGF Levels and Cognitive Function in Breast Cancer Patients: A Longitudinal Study
Terence Ng et al.
CLINICAL BREAST CANCER (2018)
Proinflammatory Factors Mediate Paclitaxel-Induced Impairment of Learning and Memory
Zhao Li et al.
MEDIATORS OF INFLAMMATION (2018)
Peroxisomes contribute to oxidative stress in neurons during doxorubicin-based chemotherapy
Jose F. Moruno-Manchon et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2018)
Resveratrol, a natural polyphenol, prevents chemotherapy-induced cognitive impairment: Involvement of cytokine modulation and neuroprotection
Dong-Dong Shi et al.
NEUROBIOLOGY OF DISEASE (2018)
Physical exercise prevents cognitive impairment by enhancing hippocampal neuroplasticity and mitochondrial function in doxorubicin-induced chemobrain
Hye-Sang Park et al.
NEUROPHARMACOLOGY (2018)
Naringin Ameliorates Doxorubicin-induced Neurotoxicity In vitro and Cognitive Dysfunction In vivo
Grandhi Venkata Ramalingayya et al.
PHARMACOGNOSY MAGAZINE (2018)
Investigation of chemotherapy-induced brain structural alterations in breast cancer patients with generalized q-sampling MRI and graph theoretical analysis
Tsung-Yuan Li et al.
BMC CANCER (2018)
Low Sucrose, Omega-3 Enriched Diet Has Region-Specific Effects on Neuroinflammation and Synaptic Function Markers in a Mouse Model of Doxorubicin-Based Chemotherapy
Tonya S. Orchard et al.
NUTRIENTS (2018)
Inflammation markers and cognitive performance in breast cancer survivors 20 years after completion of chemotherapy: a cohort study
Kimberly D. van der Willik et al.
BREAST CANCER RESEARCH (2018)
Mitoxantrone is More Toxic than Doxorubicin in SH-SY5Y Human Cells: A Chemobrain' In Vitro Study
Daniela Almeida et al.
PHARMACEUTICALS (2018)
Chronic Treatment with Combined Chemotherapeutic Agents Affects Hippocampal Micromorphometry and Function in Mice, Independently of Neuroinflammation
Sohi Kang et al.
EXPERIMENTAL NEUROBIOLOGY (2018)
Changes in brain white matter integrity after systemic treatment for breast cancer: a prospective longitudinal study
Sanne Menning et al.
BRAIN IMAGING AND BEHAVIOR (2018)
In vivo neuroimaging and behavioral correlates in a rat model of chemotherapy-induced cognitive dysfunction
Robert L. Barry et al.
BRAIN IMAGING AND BEHAVIOR (2018)
Assessing brain volume changes in older women with breast cancer receiving adjuvant chemotherapy: a brain magnetic resonance imaging pilot study
Bihong T. Chen et al.
BREAST CANCER RESEARCH (2018)
Clearing the fog: a review of the effects of dietary omega-3 fatty acids and added sugars on chemotherapy-induced cognitive deficits
Tonya S. Orchard et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Verbal fluency in breast cancer patients treated with chemotherapy
Paulina Andryszak et al.
BREAST CANCER (2017)
Cognitive impairment following hormone therapy: current opinion of research in breast and prostate cancer patients
Lisa M. Wu et al.
CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE (2017)
Anthracyclines in Early Breast Cancer: The ABC Trials-USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology)
Joanne L. Blum et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Insulin Protects against Brain Oxidative Stress with an Apparent Effect on Episodic Memory in Doxorubicin-Induced Cognitive Dysfunction in Wistar Rats
Grandhi Venkata Ramalingayya et al.
JOURNAL OF ENVIRONMENTAL PATHOLOGY TOXICOLOGY AND ONCOLOGY (2017)
Cognitive impairment in breast cancer survivors treated with chemotherapy depends on control group type and cognitive domains assessed: A multilevel meta-analysis
Lori J. Bernstein et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2017)
Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer
Gunter von Minckwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Intraindividual variability in reaction time before and after neoadjuvant chemotherapy in women diagnosed with breast cancer
Christie Yao et al.
PSYCHO-ONCOLOGY (2017)
Effects of compensatory cognitive training intervention for breast cancer patients undergoing chemotherapy: a pilot study
Jin-Hee Park et al.
SUPPORTIVE CARE IN CANCER (2017)
Abnormal Development of Dendrites in Adult-Born Rat Hippocampal Granule Cells Induced by Cyclophosphamide
Lin Wu et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2017)
Rutin protects against neuronal damage in vitro and ameliorates doxorubicin-induced memory deficits in vivo in Wistar rats
Grandhi Venkata Ramalingayya et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2017)
Characterization and reversal of Doxorubicin-mediated biphasic activation of ERK and persistent excitability in sensory neurons of Aplysia californica
Harini Lakshminarasimhan et al.
SCIENTIFIC REPORTS (2017)
A novel preventive therapy for paclitaxel-induced cognitive deficits: preclinical evidence from C57BL/6 mice
P. Huehnchen et al.
TRANSLATIONAL PSYCHIATRY (2017)
The cancer chemotherapeutic agent paclitaxel (Taxol) reduces hippocampal neurogenesis via down-regulation of vesicular zinc
Bo Eun Lee et al.
SCIENTIFIC REPORTS (2017)
Acute treatment with doxorubicin affects glutamate neurotransmission in the mouse frontal cortex and hippocampus
Theresa Currier Thomas et al.
BRAIN RESEARCH (2017)
Role of taxanes in chemotherapy-related cognitive impairment: A prospective longitudinal study
Noemi Cerulla et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Cognitive impairment in the first year after breast cancer diagnosis: A prospective cohort study
Mariana Ramalho et al.
BREAST (2017)
How 21-gene recurrence score assay is being used to individualize adjuvant chemotherapy recommendations in ER+/HER2-node positive breast cancer -A national cancer data base study
P. P. Peethambaram et al.
CANCER RESEARCH (2017)
A study of donepezil in female breast cancer survivors with self-reported cognitive dysfunction 1 to 5 years following adjuvant chemotherapy
J. A. Lawrence et al.
JOURNAL OF CANCER SURVIVORSHIP (2016)
TFEB ameliorates the impairment of the autophagy-lysosome pathway in neurons induced by doxorubicin
Jose Felix Moruno Manchon et al.
AGING-US (2016)
Doxorubicin and cyclophosphamide lead to long-lasting impairment of spatial memory in female, but not male mice
Rex M. Philpot et al.
BEHAVIOURAL BRAIN RESEARCH (2016)
Neurobiological changes by cytotoxic agents in mice
R. Seigers et al.
BEHAVIOURAL BRAIN RESEARCH (2016)
Long-lasting impairments in adult neurogenesis, spatial learning and memory from a standard chemotherapy regimen used to treat breast cancer
Catarina Rendeiro et al.
BEHAVIOURAL BRAIN RESEARCH (2016)
Post-treatment with cotinine improved memory and decreased depressive-like behavior after chemotherapy in rats
Alexandre Iarkov et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
Minocycline, a putative neuroprotectant, co-administered with doxorubicin-cyclophosphamide chemotherapy in a xenograft model of triple-negative breast cancer
Lauren E. Himmel et al.
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY (2016)
Physical exercise mitigates doxorubicin-induced brain cortex and cerebellum mitochondrial alterations and cellular quality control signaling
I Marques-Aleixo et al.
MITOCHONDRION (2016)
Naringin and Sertraline Ameliorate Doxorubicin-Induced Behavioral Deficits Through Modulation of Serotonin Level and Mitochondrial Complexes Protection Pathway in Rat Hippocampus
Mohit Kwatra et al.
NEUROCHEMICAL RESEARCH (2016)
A clinically relevant dose of cyclophosphamide chemotherapy impairs memory performance on the delayed spatial alternation task that is sustained over time as mice age
Michelle C. Janelsins et al.
NEUROTOXICOLOGY (2016)
Decline in Cognitive Function in Older AdultsWith Early-Stage Breast Cancer After Adjuvant Treatment
Marie Lange et al.
ONCOLOGIST (2016)
Acute treatment with doxorubicin induced neurochemical impairment of the function of dopamine system in rat brain structures
Lucyna Antkiewicz-Michaluk et al.
PHARMACOLOGICAL REPORTS (2016)
Long Chain Omega-3 Polyunsaturated Fatty Acid Supplementation Alleviates Doxorubicin-Induced Depressive-Like Behaviors and Neurotoxicity in Rats: Involvement of Oxidative Stress and Neuroinflammation
Yan-Qin Wu et al.
NUTRIENTS (2016)
Levetiracetam mitigates doxorubicin-induced DNA and synaptic damage in neurons
Jose Felix Moruno Manchon et al.
SCIENTIFIC REPORTS (2016)
PET Evidence of the Effect of Donepezil on Cognitive Performance in an Animal Model of Chemobrain
Ilhan Lim et al.
BIOMED RESEARCH INTERNATIONAL (2016)
Neurotoxic Effects of Anthracycline- vs Nonanthracycline-Based Chemotherapy on Cognition in Breast Cancer Survivors
Shelli R. Kesler et al.
JAMA ONCOLOGY (2016)
Moderate Physical Activity Mediates the Association between White Matter Lesion Volume and Memory Recall in Breast Cancer Survivors
Gillian E. Cooke et al.
PLOS ONE (2016)
Long-term cognitive dysfunction in the rat following docetaxel treatment is ameliorated by the phosphodiesterase-4 inhibitor, rolipram
Charlotte K. Callaghan et al.
BEHAVIOURAL BRAIN RESEARCH (2015)
Doxorubicin and cyclophosphamide induce cognitive dysfunction and activate the ERK and AKT signaling pathways
Kaliris Y. Salas-Ramirez et al.
BEHAVIOURAL BRAIN RESEARCH (2015)
Doxorubicin and cyclophosphamide treatment produces anxiety-like behavior and spatial cognition impairment in rats: Possible involvement of hippocampal neurogenesis via brain-derived neurotrophic factor and cyclin D1 regulation
Yoshihisa Kitamura et al.
BEHAVIOURAL BRAIN RESEARCH (2015)
Cognitive Function in Patients With Colorectal Cancer Who Do and Do Not Receive Chemotherapy: A Prospective, Longitudinal, Controlled Study
Janette L. Vardy et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Naringin Abrogates Cisplatin-Induced Cognitive Deficits and Cholinergic Dysfunction Through the Down-Regulation of AChE Expression and iNOS Signaling Pathways in Hippocampus of Aged Rats
Yassine Chtourou et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2015)
Adjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive Breast Cancer
Sara M. Tolaney et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Plasma TNF-α and Soluble TNF Receptor Levels after Doxorubicin with or without Co-Administration of Mesna-A Randomized, Cross-Over Clinical Study
John Hayslip et al.
PLOS ONE (2015)
Late effects of adjuvant chemotherapy for breast cancer on fine motor function
Yoo Young Hoogendam et al.
PSYCHO-ONCOLOGY (2015)
Cognitive rehabilitation group intervention for breast cancer survivors: results of a randomized clinical trial
L. M. Ercoli et al.
PSYCHO-ONCOLOGY (2015)
Clinical Characteristics, Pathophysiology, and Management of Noncentral Nervous System Cancer-Related Cognitive Impairment in Adults
Jeffrey S. Wefel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Perceived Stress Levels, Chemotherapy, Radiation Treatment and Tumor Characteristics Are Associated with a Persistent Increased Frequency of Somatic Chromosomal Instability in Women Diagnosed with Breast Cancer: A One Year Longitudinal Study
Noran Aboalela et al.
PLOS ONE (2015)
Relationship between exercise behavior, cardiorespiratory fitness, and cognitive function in early breast cancer patients treated with doxorubicin-containing chemotherapy: a pilot study
Theresa Crowgey et al.
APPLIED PHYSIOLOGY NUTRITION AND METABOLISM (2014)
Dysregulation in myelination mediated by persistent neuroinflammation: Possible mechanisms in chemotherapy-related cognitive impairment
Teresita L. Briones et al.
BRAIN BEHAVIOR AND IMMUNITY (2014)
A Randomized, Double-blind, 2-Period, Placebo-Controlled Crossover Trial of a Sustained-Release Methylphenidate in the Treatment of Fatigue in Cancer Patients
Carmen P. Escalante et al.
CANCER JOURNAL (2014)
The genetic variants underlying breast cancer treatment-induced chronic and late toxicities: A systematic review
Terence Ng et al.
CANCER TREATMENT REVIEWS (2014)
Global and focal white matter integrity in breast cancer survivors 20 years after adjuvant chemotherapy
Vincent Koppelmans et al.
HUMAN BRAIN MAPPING (2014)
Cognitive Dysfunction after Chemotherapy For Breast Cancer
Kim Edelstein et al.
JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY (2014)
Altered Cerebral Blood Flow One Month after Systemic Chemotherapy for Breast Cancer: A Prospective Study Using Pulsed Arterial Spin Labeling MRI Perfusion
Kelly N. H. Nudelman et al.
PLOS ONE (2014)
Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: the impact of APOE and smoking
Tim A. Ahles et al.
PSYCHO-ONCOLOGY (2014)
Physical exercise prevents suppression of hippocampal neurogenesis and reduces cognitive impairment in chemotherapy-treated rats
Gordon Winocur et al.
PSYCHOPHARMACOLOGY (2014)
The impact of sustained and intermittent docetaxel chemotherapy regimens on cognition and neural morphology in healthy mice
Joanna E. Fardell et al.
PSYCHOPHARMACOLOGY (2014)
Assessment of the feasibility of a rehabilitation intervention program for breast cancer survivors with cognitive complaints
Linda M. Ercoli et al.
BRAIN IMAGING AND BEHAVIOR (2013)
Cognitive function in older women with breast cancer treated with standard chemotherapy and capecitabine on Cancer and Leukemia Group B 49907
Rachel A. Freedman et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Cognitive Training for Improving Executive Function in Chemotherapy-Treated Breast Cancer Survivors
Shelli Kesler et al.
CLINICAL BREAST CANCER (2013)
The Effect of EEG Biofeedback on Reducing Postcancer Cognitive Impairment
Jean Alvarez et al.
INTEGRATIVE CANCER THERAPIES (2013)
The short and long term effects of docetaxel chemotherapy on rodent object recognition and spatial reference memory
Joanna E. Fardell et al.
LIFE SCIENCES (2013)
Is basic research providing answers if adjuvant anti-estrogen treatment of breast cancer can induce cognitive impairment?
Bauke Buwalda et al.
LIFE SCIENCES (2013)
Apolipoprotein A-I: Insights from redox proteomics for its role in neurodegeneration
Jeriel T. R. Keeney et al.
PROTEOMICS CLINICAL APPLICATIONS (2013)
Cognitive effects of chemotherapy in breast cancer patients: a dose-response study
Barbara Collins et al.
PSYCHO-ONCOLOGY (2013)
The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9
Debra L. Barton et al.
SUPPORTIVE CARE IN CANCER (2013)
The impact of cancer therapy on cognition in the elderly
Victoria Mandilaras et al.
FRONTIERS IN PHARMACOLOGY (2013)
A pilot study: Application of hemoglobin and cortisol levels, and a memory test to evaluate the quality of life of breast cancer patients on chemotherapy
Wings T. Y. Loo et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2013)
Preserved learning and memory in mice following chemotherapy: 5-Fluorouracil and doxorubicin single agent treatment, doxorubicin-cyclophosphamide combination treatment
Thane Fremouw et al.
BEHAVIOURAL BRAIN RESEARCH (2012)
Advanced cognitive training for breast cancer survivors: a randomized controlled trial
Diane Von Ah et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Impaired Cognitive Function and Hippocampal Neurogenesis following Cancer Chemotherapy
Lori-Ann Christie et al.
CLINICAL CANCER RESEARCH (2012)
Neuro-cognitive impairment in breast cancer patients: Pharmacological considerations
Yin Ting Cheung et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2012)
Chemotherapy-Related Cognitive Dysfunction
Jeffrey S. Wefel et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2012)
Prevention of paclitaxel-induced peripheral neuropathy by lithium pretreatment
Michelle Mo et al.
FASEB JOURNAL (2012)
Neuropsychological Performance in Survivors of Breast Cancer More Than 20 Years After Adjuvant Chemotherapy
Vincent Koppelmans et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Cancer- and Cancer Treatment-Associated Cognitive Change: An Update on the State of the Science
Tim A. Ahles et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
Luca Gianni et al.
LANCET ONCOLOGY (2012)
Development of CBT for chemotherapy-related cognitive change: results of a waitlist control trial
Robert J. Ferguson et al.
PSYCHO-ONCOLOGY (2012)
Cognitive impairments caused by oxaliplatin and 5-fluorouracil chemotherapy are ameliorated by physical activity
Joanna E. Fardell et al.
PSYCHOPHARMACOLOGY (2012)
Differential expression of cytokines in breast cancer patients receiving different chemotherapies: implications for cognitive impairment research
Michelle C. Janelsins et al.
SUPPORTIVE CARE IN CANCER (2012)
Tumour necrosis factor - alpha mediated mechanisms of cognitive dysfunction
Bernhard T. Baune et al.
TRANSLATIONAL NEUROSCIENCE (2012)
Assessing the Relationship Between Physical Fitness Activities, Cognitive Health, and Quality of Life Among Older Cancer Survivors
Tanya R. Fitzpatrick et al.
JOURNAL OF PSYCHOSOCIAL ONCOLOGY (2012)
Balancing repair and tolerance of DNA damage caused by alkylating agents
Dragony Fu et al.
NATURE REVIEWS CANCER (2012)
Chemotherapy-induced cognitive impairment is associated with decreases in cell proliferation and histone modifications
Teresita L. Briones et al.
BMC NEUROSCIENCE (2011)
Crosstalk of reactive oxygen species and NF-kappa B signaling
Michael J. Morgan et al.
CELL RESEARCH (2011)
Peripheral Neuropathy with Microtubule-Targeting Agents: Occurrence and Management Approach
Karen Carlson et al.
CLINICAL BREAST CANCER (2011)
2-Mercaptoethane sulfonate prevents doxorubicin-induced plasma protein oxidation and TNF-α release: Implications for the reactive oxygen species-mediated mechanisms of chemobrain
Christopher D. Aluise et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Four-Year Follow-Up of Trastuzumab Plus Adjuvant Chemotherapy for Operable Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Joint Analysis of Data From NCCTG N9831 and NSABP B-31
Edith A. Perez et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer
Jeffrey S. Wefel et al.
LANCET ONCOLOGY (2011)
DOXORUBICIN-INDUCED CENTRAL NERVOUS SYSTEM TOXICITY AND PROTECTION BY XANTHONE DERIVATIVE OF GARCINIA MANGOSTANA
J. Tangpong et al.
NEUROSCIENCE (2011)
Adjuvant Trastuzumab in HER2-Positive Breast Cancer
Dennis Slamon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Preserved learning and memory following 5-fluorouracil and cyclophosphamide treatment in rats
Jeffrey M. Long et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2011)
A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients
Catherine E. Jansen et al.
SUPPORTIVE CARE IN CANCER (2011)
Fluoxetine improves the memory deficits caused by the chemotherapy agent 5-fluorouracil
Maha ELBeltagy et al.
BEHAVIOURAL BRAIN RESEARCH (2010)
Cognitive function after adjuvant treatment for early breast cancer: a population-based longitudinal study
Jeanne Debess et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Acute and Late Onset Cognitive Dysfunction Associated With Chemotherapy in Women With Breast Cancer
Jeffrey S. Wefel et al.
CANCER (2010)
IGF-1 Partially Restores Chemotherapy-Induced Reductions in Neural Cell Proliferation in Adult C57BL/6 Mice
Michelle C. Janelsins et al.
CANCER INVESTIGATION (2010)
Voluntary Running Prevents Progressive Memory Decline and Increases Adult Hippocampal Neurogenesis and Growth Factor Expression after Whole-Brain Irradiation
Sarah J. E. Wong-Goodrich et al.
CANCER RESEARCH (2010)
Biodistribution and radiation dosimetry of 11C-labelled docetaxel in cancer patients
Astrid A. M. van der Veldt et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
Longitudinal Assessment of Cognitive Changes Associated With Adjuvant Treatment for Breast Cancer: Impact of Age and Cognitive Reserve
Tim A. Ahles et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Cyclophosphamide impairs hippocampus-dependent learning and memory in adult mice: Possible involvement of hippocampal neurogenesis in chemotherapy-induced memory deficits
Miyoung Yang et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2010)
Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: Cross-sectional findings from the neuropsychological TEAM-side study
Christina M. Schilder et al.
ACTA ONCOLOGICA (2009)
The Effect of Modafinil on Cognitive Function in Breast Cancer Survivors
Sadhna Kohli et al.
CANCER (2009)
Regional Brain Activation during Verbal Declarative Memory in Metastatic Breast Cancer
Shelli R. Kesler et al.
CLINICAL CANCER RESEARCH (2009)
Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735
Stephen Jones et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Efficacy of Dexmethylphenidate for the Treatment of Fatigue After Cancer Chemotherapy: A Randomized Clinical Trial
Elyse E. Lower et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2009)
Differential effects of paclitaxel treatment on cognitive functioning and mechanical sensitivity
Jessica A. Boyette-Davis et al.
NEUROSCIENCE LETTERS (2009)
Modafinil for attentional and psychomotor dysfunction in advanced cancer: a double-blind, randomised, cross-over trial
L. E. Lundorff et al.
PALLIATIVE MEDICINE (2009)
Systemic administration of doxorubicin impairs aversively motivated memory in rats
Pedro Emanuel Rubini Liedke et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2009)
The influence of erythropoietin on cognitive function in women following chemotherapy for breast cancer
H. G. Mar Fan et al.
PSYCHO-ONCOLOGY (2009)
Effects of Specific Neuropsychological Training Programs for Breast Cancer Patients After Adjuvant Chemotherapy
M. Poppelreuter et al.
JOURNAL OF PSYCHOSOCIAL ONCOLOGY (2009)
Redox regulation of cell survival
Dunyaporn Trachootham et al.
ANTIOXIDANTS & REDOX SIGNALING (2008)
Adjuvant chemotherapy for breast cancer: Effects on cerebral white matter seen in diffusion tensor imaging
Jame Abraham et al.
CLINICAL BREAST CANCER (2008)
Persistent neurocognitive problems after adjuvant chemotherapy for breast cancer
Baudewijntje P. C. Kreukels et al.
CLINICAL BREAST CANCER (2008)
5-fluorouracil chemotherapy affects spatial working memory and newborn neurons in the adult rat hippocampus
Sarah Mustafa et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2008)
Donepezil: potential neuroprotective and disease-modifying effects
Sandra A. Jacobson et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2008)
Weekly paclitaxel in the adjuvant treatment of breast cancer
Joseph A. Sparano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
A randomised, placebo-controlled, double-blind trial of the effects of d-methylphenidate on fatigue and cognitive dysfunction in women undergoing adjuvant chemotherapy for breast cancer
Helen G. Mar Fan et al.
SUPPORTIVE CARE IN CANCER (2008)
Prospective evaluation of cognitive function in patients with early breast cancer receiving adjuvant chemotherapy
Michelle Ruzich et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2007)
Cognitive-behavioral management of chemotherapy-related cognitive change
Robert J. Ferguson et al.
PSYCHO-ONCOLOGY (2007)
Chronic exposure to paclitaxel diminishes phosphoinositide signaling by calpain-mediated neuronal calcium sensor-1 degradation
Wolfgang Boehmerle et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Cognitive function during neoadjuvant chemotherapy for breast cancer -: Results of a prospective, multicenter, longitudinal study
Kerstin Hermelink et al.
CANCER (2007)
Cognitive function after chemotherapy in adults with solid tumours
Janette Vardy et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2007)
Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients
Sanne B. Schagen et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
NF-κB activation by reactive oxygen species:: Fifteen years later
Geoffrey Gloire et al.
BIOCHEMICAL PHARMACOLOGY (2006)
Paclitaxel induces calcium oscillations via an inositol 1,4,5-trisphosphate receptor and neuronal calcium sensor 1-dependent mechanism
Wolfgang Boehmerle et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Adriamycin-induced, TNF-α-mediated central nervous system toxicity
Jitanjong Tangpong et al.
NEUROBIOLOGY OF DISEASE (2006)
Peripheral neuropathy induced by paclitaxel: Recent insights and future perspectives
CD Scripture et al.
CURRENT NEUROPHARMACOLOGY (2006)
Effects of high-dose and conventional-dose adjuvant chemotherapy on long-term cognitive sequelae in patients with breast cancer: An electrophysiologic study
Baudewijntje P. C. Kreukels et al.
CLINICAL BREAST CANCER (2006)
Neuropsychological function in high-risk breast cancer survivors after stem-cell supported high-dose therapy versus standard-dose chemotherapy: evaluation of long-term treatment effects
A Scherwath et al.
ANNALS OF ONCOLOGY (2006)
Transient improvement in cognitive function and synaptic plasticity in rats following cancer chemotherapy
GD Lee et al.
CLINICAL CANCER RESEARCH (2006)
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Adjuvant docetaxel for node-positive breast cancer
M Martin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Cellular processing of platinum anticancer drugs
D Wang et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
TNFα potentiates glutamate neurotoxicity by inhibiting glutamate uptake in organotypic brain slice cultures:: neuroprotection by NFκB inhibition
JY Zou et al.
BRAIN RESEARCH (2005)
A historical review of cellular calcium handling, with emphasis on mitochondria
NEL Saris et al.
BIOCHEMISTRY-MOSCOW (2005)
Microtubules as a target for anticancer drugs
MA Jordan et al.
NATURE REVIEWS CANCER (2004)
Relationship of hemoglobin levels to fatigue and cognitive functioning among cancer patients receiving chemotherapy
PB Jacobsen et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2004)
Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity
G Minotti et al.
PHARMACOLOGICAL REVIEWS (2004)
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
L Santarelli et al.
SCIENCE (2003)
Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: First report of intergroup trial C9741/cancer and leukemia group B trial 9741
ML Citron et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients
SB Schagen et al.
ANNALS OF ONCOLOGY (2002)
Paclitaxel affects cytosolic calcium signals by opening the mitochondrial permeability transition pore
JF Kidd et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Direct effect of taxol on free radical formation and mitochondrial permeability transition
G Varbiro et al.
FREE RADICAL BIOLOGY AND MEDICINE (2001)
Apolipoprotein A-I inhibits the production of interleukin-1β and tumor necrosis factor-α by blocking contact-mediated activation of monocytes by T lymphocytes
N Hyka et al.
BLOOD (2001)
Share Paper
